COLYMONAS 2MIU

Coly-monas 2MIU Injection contains the active ingredient Colistimethate sodium. This antibiotic is part of a class of medications known as polymyxins. It is utilized to address specific bacterial infections. This medication is often prescribed when other antibiotics are not appropriate. In some cases, it is administered via inhalation to manage chronic lung infections in individuals with cystic fibrosis.

This medication is indicated for infections caused by particular bacteria known as Pseudomonas aeruginosa. Avoid using Coly-monas 2MIU Injection if you have an allergy to colistimethate sodium, colistin, or any other components of the medication. Notify your physician if you have kidney issues, myasthenia gravis (a condition characterized by muscle weakness), porphyria (a set of disorders resulting from excessive porphyrin accumulation, which is essential for hemoglobin, the oxygen-carrying protein in blood), or asthma. Inform your doctor if you are pregnant, nursing, or planning to conceive during the course of treatment.

Severe allergic reactions may occur even after the initial dose of Coly-monas 2MIU Injection in some individuals. Symptoms can include the rapid onset of rashes, swelling of the face, tongue, and neck, and difficulty breathing. It is crucial to seek immediate medical help if you notice any signs of an allergic reaction. Do not discontinue your treatment prematurely without consulting your physician. Your doctor will determine the appropriate duration of your treatment.